Thread by @SamJamesMorgan

💉 BREAKING - EU medicines agency is assessing the J&J single-dose COVID vax, after pharma firm applied for approval. Decision due mid-March under "accelerated timetable"

Commission has 200m doses on order, with option for 200m more. Latest data from US trials shows 72% efficacy vs moderate/severe infection, 85% vs hospitalisation/death

Could be a real game-changer this one. Touted as a covid-manager rather than covid-tamer. Lower efficacy but easier to get people jabbed due to the single-dose

Something to be happy about

*decision due mid-March IF there's enough data etc. EMA has delayed before, could again. But there's a landing zone

Oh and on the variants, J&J has this to say: "Protection Against Severe Disease Across Geographies, Ages, and Multiple Virus Variants" including the South Africa strain

So more good news

Good news in 3s: J&J esimates that the jab is good for two years at -20°C, at least three months of which can be at temperatures of 2-8°C

*4s. Also this:

https://twitter.com/APHClarkson/status/1361703537365962754?s=20

As always, el Rey @europressos was ahead of us all. If you don’t follow/read him you’re a mug eleconomista.es/empresas-finan…